Related Experiment Video
Updated: Jul 1, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Cardiogenic Shock in a Patient With 4G/4G PAI Polymorphism and MTHFR A1298C Mutation.
Ijeoma Orabueze1, Inemesit Akpan2, Valerie Cluzet3
1Internal Medicine, Vassar Brothers Medical Center, Poughkeepsie, USA.
This case study highlights a 75-year-old male with inherited thrombophilia and peripheral artery disease who experienced acute myocardial infarction (MI) and cardiogenic shock despite no prior cardiac history.
Area of Science:
- Cardiology
- Genetics
- Vascular Medicine
Background:
- Myocardial infarction (MI) is a leading cause of death, with established risk factors.
- The link between inherited thrombophilia and acute MI is not fully understood.
- Genetic predispositions like PAI-1 polymorphism and MTHFR mutations may influence thrombotic events.
Observation:
- A 75-year-old male with known 4G/4G PAI-1 polymorphism, methylenetetrahydrofolate reductase (MTHFR) mutation, and peripheral artery disease (PAD) presented with acute MI.
- The patient experienced cardiogenic shock.
- Notably, the patient had no prior significant cardiac history.
Findings:
- This case illustrates a potential association between specific inherited thrombophilia disorders (PAI-1 4G/4G, MTHFR mutation) and acute MI.
- The presence of PAD and prior stenting may have contributed to the thrombotic event.
- The acute MI led to cardiogenic shock in the absence of previous cardiac disease.
Implications:
- Further research is warranted to elucidate the role of inherited thrombophilia in acute MI, particularly in patients with vascular comorbidities.
- Identifying individuals with these genetic risk factors could enable proactive cardiovascular risk management.
- This case underscores the importance of considering thrombophilia in patients presenting with unexplained acute coronary syndromes.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Pathophysiology of Heart Failure
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...